◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Himadri Speciality Chemical Limited (HSCL) Revenue 2022–2026

Name: Himadri Speciality Chemical Limited (HSCL) revenue history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Himadri Speciality Chemical Limited annual revenue for fiscal 2026 was ₹46.6 billion, an increase of 1.3% from ₹46.0 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

HSCL Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹46.6B	₹46.0B	₹41.8B	₹41.7B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSCL Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹14.3B	₹12.9B	₹11.8B	₹11.2B	₹11.3B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

4401 Revenue — Adeka Corporation
5301 Revenue — Tokai Carbon Co., Ltd.
4202 Revenue — Daicel Corporation
4118 Revenue — Kaneka Corporation
7966 Revenue — LINTEC Corporation
4208 Revenue — UBE Corporation

More HSCL metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All HSCL financial statements → Interactive HSCL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.